PET 6-[(18)F]fluoro-L-m-tyrosine Studies of Dopaminergic Function in Human and Nonhuman Primates

Por Eberling, Jamie L., Bankiewicz, Krystof S., O'Neil, James P., Jagust, William J.
Publicado em 2008

Eight Years of Clinical Improvement in MPTP-Lesioned Primates After Gene Therapy With AAV2-hAADC

Por Hadaczek, Piotr, Eberling, Jamie L, Pivirotto, Philip, Bringas, John, Forsayeth, John, Bankiewicz, Krystof S
Publicado em 2010

Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeys

Por Bankiewicz, Krystof S., Daadi, Marcel, Pivirotto, Philip, Bringas, John, Sanftner, Laura, Cunningham, Janet, Forsayeth, John R., Eberling, Jamie L.
Publicado em 2005

Functional Effects of AAV2-GDNF on the Dopaminergic Nigrostriatal Pathway in Parkinsonian Rhesus Monkeys

Por Eberling, Jamie L., Kells, Adrian P., Pivirotto, Philip, Beyer, Janine, Bringas, John, Federoff, Howard J., Forsayeth, John, Bankiewicz, Krystof S.
Publicado em 2009

A Dose-Ranging Study of AAV-hAADC Therapy in Parkinsonian Monkeys

Por Forsayeth, John R., Eberling, Jamie L., Sanftner, Laura M., Zhen, Zhu, Pivirotto, Philip, Bringas, John, Cunningham, Janet, Bankiewicz, Krystof S.
Publicado em 2006

Effects of Subcortical Cerebral Infarction on Cortical Glucose Metabolism and Cognitive Function

Por Kwan, Lawrence T., Reed, Bruce R., Eberling, Jamie L., Schuff, Norbert, Tanabe, Jody, Norman, David, Weiner, Michael W., Jagust, William J.
Publicado em 1999